ANIK Q1 2020 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$35M+43.2% YoY

Gross Profit

$21M59.9% margin

Operating Income

$7M20.0% margin

Net Income

$6M16.4% margin

EPS (Diluted)

$0.40

QoQ Revenue Growth

+18.9%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$322,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$399M

Total Liabilities

$105M

Stockholders' Equity

$294M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$25M	+43.2%
Gross Profit	$21M	$17M	+21.7%
Operating Income	$7M	$5M	+29.4%
Net Income	$6M	$5M	+28.5%

Revenue Segments

Product

$35M50%

Joint Pain Management Therapies

$25M36%

Orthopedic Joint Preservation and Restoration Care

$8M11%

Manufactured Product, Other

$2M3%

Geographic Segments

UNITED STATES

$26M83%

Europe

$5M17%